<p>A) Docking pose of etoposide relative to Top2α. Protein backbone and surface shown in cyan. Two residues interacting with etoposide are shown as sticks. B) Docking pose of etoposide relative to DNA. DNA residues shown as green sticks. Hydrogen bonds indicated as green, hydrophobic interactions as blue and stacking interactions as orange lines. C) and D) 2D- and 3D-representation of complex-based pharmacophore developed from the etoposide docking pose. Colour code of pharmacophore features: hydrogen bond acceptor (HBA), green; hydrogen bond donor (HBD), pink; hydrophobic group, blue; cyclic π-interaction (CYPI), orange; excluded volume, grey.</p
<p>Compound <b>41</b> is shown in cyan backbone, compound <b>22</b> is shown in magenta backbone, an...
Etoposide is one of the most successful chemotherapeutic agents used for the treatment of human canc...
<p>Ligands are shown as gray sticks; receptor residues are shown as green sticks. Bonds are shown wi...
<p>Active site residues are shown in stick form. PD00519 and compound 1 are color-coded: green – PD0...
<p>(A) Three-dimensional representation of the interactions of compound 13 and target protein. (B) P...
<p>Etoposide docked into the (A) glutamine-containing Bristol TOP-2 enzyme (Δ<i>G</i> = -10.09 kcal/...
<p>Superimposition of Top2α homology model (dark cyan) and Top2β crystal structure (light blue) <a h...
<p>(A and B) The panel of poses represent the molecular docking interactions of C-10 and Etoposide l...
Fig. 6. Molecular docking simulations of iNOS (A) and COX-2 (B) with bioactive compound 3 (colored b...
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C, D) DCS]- Aβ-42 interaction.</p
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C,D) DCS]-HEWL interaction.</p
ABSTRACT: Etoposide is one of the most successful chemotherapeutic agents used for the treatment of ...
<p>(A) 3D visualization of predicted drug binding to the DNA-binding domain (leucine zipper) of AP-1...
<p>(A) Coproporphyrinogen III (B) isopraeroside IV (C) scopolin (D) nodakenin. Orange solid lines an...
<p>The key pharmacophoric features generated from the binding modes of (A) C1 and (B) Ang I. The ami...
<p>Compound <b>41</b> is shown in cyan backbone, compound <b>22</b> is shown in magenta backbone, an...
Etoposide is one of the most successful chemotherapeutic agents used for the treatment of human canc...
<p>Ligands are shown as gray sticks; receptor residues are shown as green sticks. Bonds are shown wi...
<p>Active site residues are shown in stick form. PD00519 and compound 1 are color-coded: green – PD0...
<p>(A) Three-dimensional representation of the interactions of compound 13 and target protein. (B) P...
<p>Etoposide docked into the (A) glutamine-containing Bristol TOP-2 enzyme (Δ<i>G</i> = -10.09 kcal/...
<p>Superimposition of Top2α homology model (dark cyan) and Top2β crystal structure (light blue) <a h...
<p>(A and B) The panel of poses represent the molecular docking interactions of C-10 and Etoposide l...
Fig. 6. Molecular docking simulations of iNOS (A) and COX-2 (B) with bioactive compound 3 (colored b...
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C, D) DCS]- Aβ-42 interaction.</p
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C,D) DCS]-HEWL interaction.</p
ABSTRACT: Etoposide is one of the most successful chemotherapeutic agents used for the treatment of ...
<p>(A) 3D visualization of predicted drug binding to the DNA-binding domain (leucine zipper) of AP-1...
<p>(A) Coproporphyrinogen III (B) isopraeroside IV (C) scopolin (D) nodakenin. Orange solid lines an...
<p>The key pharmacophoric features generated from the binding modes of (A) C1 and (B) Ang I. The ami...
<p>Compound <b>41</b> is shown in cyan backbone, compound <b>22</b> is shown in magenta backbone, an...
Etoposide is one of the most successful chemotherapeutic agents used for the treatment of human canc...
<p>Ligands are shown as gray sticks; receptor residues are shown as green sticks. Bonds are shown wi...